Delivering insights that drive actionable strategy
We provide key business critical assessments, strategic evaluations and critical milestone analysis across your product journey
Strategy & Commercialization
New Product Planning
- Opportunity Mapping
- Commercial Assessments & Indication Prioritization
- GtM Strategy, including:
- Revenue Forecasting
- Target market definition
- Customer segmentation
- Patient journey and treatment leverage points
- Regulatory landscape analysis
- Competitive landscaping
- Indication sequencing and product lifecycle strategy
- Disease and brand communication strategy
- Target Product Profile validation
- KOL and Competitor market research
- Payer market research to drive pricing strategy
- KOL advisory boards and advocacy plans
- Market input to PoC and pivotal clinical trials
Launch Planning
- Strategic and tactical go-to-market roadmaps
- Commercial organization and resource planning
- Cross functional Day 0 Launch Planning (Launch Excellence)
- Design and build commercial data infrastructure
- Supply chain strategy and execution support
Business Development & Evaluations
In-licensing and asset scouting
- Working with the client scouting team to identify companies and assets not yet appearing in industry pipeline databases
- Applying our Asset Scouting Framework to classify attractiveness of scouted targets
- Scanning of new and recent literature to identify emerging opportunities
- Searches of grants, deals, and pipeline databases
- Outreach and networking with tech transfer offices, KOLs, industry contacts, and licensing professionals
- Contacting companies that fit our clients’ criteria to ascertain their interest in partnerships
- Targeted and regular attendance at partnering and scientific conferences
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.